Addressing the Challenges of Tuberculosis: A Brief Historical Account
Tuberculosis (TB) is a highly contagious disease that still poses a threat to human health. Mycobacterium tuberculosis (MTB), the pathogen responsible for TB, uses diverse ways in order to survive in a variety of host lesions and to subsequently evade immune surveillance; as a result, fighting TB an...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00689/full |
id |
doaj-df1f0dea33a8440a8d45fbcd08f22c8b |
---|---|
record_format |
Article |
spelling |
doaj-df1f0dea33a8440a8d45fbcd08f22c8b2020-11-24T22:41:55ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-09-01810.3389/fphar.2017.00689264120Addressing the Challenges of Tuberculosis: A Brief Historical AccountHussam W. Al-Humadi0Hussam W. Al-Humadi1Rafal J. Al-Saigh2Ahmed W. Al-Humadi3Department of Pharmacology and Toxicology, Pharmacy College, University of Babylon, Babylon, IraqLaboratory of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, GreeceDepartment of Pharmacology and Toxicology, Pharmacy College, University of Babylon, Babylon, IraqLaboratory of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, GreeceTuberculosis (TB) is a highly contagious disease that still poses a threat to human health. Mycobacterium tuberculosis (MTB), the pathogen responsible for TB, uses diverse ways in order to survive in a variety of host lesions and to subsequently evade immune surveillance; as a result, fighting TB and its associated multidrug resistance has been an ongoing challenge. The aim of this review article is to summarize the historical sequence of drug development and use in the fight against TB, with a particular emphasis on the decades between World War II and the dawn of the twenty first century (2000).http://journal.frontiersin.org/article/10.3389/fphar.2017.00689/fulltuberculosishistorytreatmentanti-TB drugsmultidrug resistancepharmaceutical innovation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hussam W. Al-Humadi Hussam W. Al-Humadi Rafal J. Al-Saigh Ahmed W. Al-Humadi |
spellingShingle |
Hussam W. Al-Humadi Hussam W. Al-Humadi Rafal J. Al-Saigh Ahmed W. Al-Humadi Addressing the Challenges of Tuberculosis: A Brief Historical Account Frontiers in Pharmacology tuberculosis history treatment anti-TB drugs multidrug resistance pharmaceutical innovation |
author_facet |
Hussam W. Al-Humadi Hussam W. Al-Humadi Rafal J. Al-Saigh Ahmed W. Al-Humadi |
author_sort |
Hussam W. Al-Humadi |
title |
Addressing the Challenges of Tuberculosis: A Brief Historical Account |
title_short |
Addressing the Challenges of Tuberculosis: A Brief Historical Account |
title_full |
Addressing the Challenges of Tuberculosis: A Brief Historical Account |
title_fullStr |
Addressing the Challenges of Tuberculosis: A Brief Historical Account |
title_full_unstemmed |
Addressing the Challenges of Tuberculosis: A Brief Historical Account |
title_sort |
addressing the challenges of tuberculosis: a brief historical account |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2017-09-01 |
description |
Tuberculosis (TB) is a highly contagious disease that still poses a threat to human health. Mycobacterium tuberculosis (MTB), the pathogen responsible for TB, uses diverse ways in order to survive in a variety of host lesions and to subsequently evade immune surveillance; as a result, fighting TB and its associated multidrug resistance has been an ongoing challenge. The aim of this review article is to summarize the historical sequence of drug development and use in the fight against TB, with a particular emphasis on the decades between World War II and the dawn of the twenty first century (2000). |
topic |
tuberculosis history treatment anti-TB drugs multidrug resistance pharmaceutical innovation |
url |
http://journal.frontiersin.org/article/10.3389/fphar.2017.00689/full |
work_keys_str_mv |
AT hussamwalhumadi addressingthechallengesoftuberculosisabriefhistoricalaccount AT hussamwalhumadi addressingthechallengesoftuberculosisabriefhistoricalaccount AT rafaljalsaigh addressingthechallengesoftuberculosisabriefhistoricalaccount AT ahmedwalhumadi addressingthechallengesoftuberculosisabriefhistoricalaccount |
_version_ |
1725700214818340864 |